M. Valerio, P. Muñoz, C. G. Rodríguez, B. Caliz, B. Padilla, A

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

C.N. van Ettekoven, D. van de Beek, M.C. Brouwer

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Herpes zoster in non-hospitalized children

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

Is antimicrobial stewardship cost-effective

Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children N. Agrinier, M. Le Maréchal,

R. Cantón Clinical Microbiology and Infection

A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J

P. Nordmann, L. Poirel Clinical Microbiology and Infection

A.E. Muller, U. Theuretzbacher, J.W. Mouton

Nocardiosis in Quebec, Canada, 1988–2008

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Dermatitis by Dermatophilus congolensis

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,

Surveillance of Legionnaires’ disease in Austria

Vector control: a cornerstone in the malaria elimination campaign

Update and new insights in encephalitis

C. Garcia-Vidal, I. Sanchez-Rodriguez, A. F. Simonetti, J. Burgos, D

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions

E. Vermeulen, J. Maertens, P. Meersseman, V. Saegeman, L. Dupont, K

Laboratory diagnosis and biosafety issues of biological warfare agents

C. Fabrizio, A. Procopio Clinical Microbiology and Infection

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit E. Theocharidou, B. Agarwal, G. Jeffrey,

Metagenomics and probiotics

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital R. Herruzo, F.

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

J.M. García-Lechuz, M. Sánchez-Conde, L. Muñoz, C. Benito

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij

Survival of rhinoviruses on human fingers

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Antifungal stewardship in a tertiary-care institution: a bedside intervention M. Valerio, P. Muñoz, C.G. Rodríguez, B. Caliz, B. Padilla, A. Fernández-Cruz, M. Sánchez-Somolinos, P. Gijón, J. Peral, J. Gayoso, I. Frias, M. Salcedo, M. Sanjurjo, E. Bouza Clinical Microbiology and Infection Volume 21, Issue 5, Pages 492.e1-492.e9 (May 2015) DOI: 10.1016/j.cmi.2015.01.013 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Monthly time series of antifungal costs (thousand of US$) from October 2007 to September 2013. The months are labelled as time periods from 1 to 72, being the 37th month (October 2010) when the antifungal stewardship programme was implemented. The figure shows the reverse in the trend of cost when the antifungal stewardship was implemented. Clinical Microbiology and Infection 2015 21, 492.e1-492.e9DOI: (10.1016/j.cmi.2015.01.013) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions